Analysis of pol gene heterogeneity, viral quasispecies, and drug resistance in individuals infected with group O strains of human immunodeficiency virus type 1.
about
Unusual distribution of mutations associated with serial bottleneck passages of human immunodeficiency virus type 1The Two-Phase Emergence of Non Pandemic HIV-1 Group O in Cameroon.Genetic analysis of West Nile virus isolates from an outbreak in Idaho, United States, 2006-2007The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates.Diversity, divergence, and evolution of cell-free human immunodeficiency virus type 1 in vaginal secretions and blood of chronically infected women: associations with immune status.Human immunodeficiency virus type 1 group m protease in cameroon: genetic diversity and protease inhibitor mutational featuresQuantitation of human immunodeficiency virus type 1 group O load in plasma by measuring reverse transcriptase activityDivergent evolution in reverse transcriptase (RT) of HIV-1 group O and M lineages: impact on structure, fitness, and sensitivity to nonnucleoside RT inhibitors.In vitro intersubtype recombinants of human immunodeficiency virus type 1: comparison to recent and circulating in vivo recombinant forms.Rapid assessment of phenotypic resistance to protease inhibitors in human immunodeficiency virus type 1 group O.HIV-1 group O integrase displays lower enzymatic efficiency and higher susceptibility to raltegravir than HIV-1 group M subtype B integraseTurnover of env variable region 1 and 2 genotypes in subjects with late-stage human immunodeficiency virus type 1 infectionA Guide to HIV-1 Reverse Transcriptase and Protease Sequencing for Drug Resistance Studies.Human immunodeficiency virus type 1 subtype distribution in the worldwide epidemic: pathogenetic and therapeutic implications.Low-Frequency Drug Resistance in HIV-Infected Ugandans on Antiretroviral Treatment Is Associated with Regimen Failure.Genetic diversity of protease and reverse transcriptase sequences in non-subtype-B human immunodeficiency virus type 1 strains: evidence of many minor drug resistance mutations in treatment-naive patients.
P2860
Q27469694-B8D41938-D34D-4378-9973-30D350A53143Q30377499-6CF86BCA-1567-4DFA-ABFC-ADFBF5931B7EQ30448143-22D6BF31-4283-4D47-AF34-DC18B0AD327DQ33884059-94296AD6-19E0-4F5C-9841-321351757F75Q33908859-DD527F83-E2E0-4949-BC1C-68FFA7178928Q33951471-8186CA16-46A0-4C3F-8F7C-B9DC77107FEEQ33974930-4B78561A-C099-4B41-9005-37412AC96F54Q34120878-3B4B6188-BF91-4717-B747-C5C9E3D87622Q34346614-28FBA5E7-9986-46CD-874C-16D73A1BE4ACQ34437450-885E1FE0-8CDA-4B68-B25C-585D1762B50EQ34597650-1AA22BB8-345E-4980-AC2A-1C94DA17F25AQ35020053-FB4ADE9F-D87E-4533-BF81-705796F2DAABQ35742512-342E5BE7-9F02-4077-8E9E-D243D7CCBAC1Q36099119-CE1BF22E-B880-4A2B-8B9B-9680229955C7Q36933330-41C3CD57-AACE-48F0-AD91-2D69B1AA4360Q39461924-FAE8B7AF-EDFB-4FAE-85AC-91998D577D74
P2860
Analysis of pol gene heterogeneity, viral quasispecies, and drug resistance in individuals infected with group O strains of human immunodeficiency virus type 1.
description
1998 nî lūn-bûn
@nan
1998 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Analysis of pol gene heterogen ...... immunodeficiency virus type 1.
@ast
Analysis of pol gene heterogen ...... immunodeficiency virus type 1.
@en
type
label
Analysis of pol gene heterogen ...... immunodeficiency virus type 1.
@ast
Analysis of pol gene heterogen ...... immunodeficiency virus type 1.
@en
prefLabel
Analysis of pol gene heterogen ...... immunodeficiency virus type 1.
@ast
Analysis of pol gene heterogen ...... immunodeficiency virus type 1.
@en
P2093
P2860
P1433
P1476
Analysis of pol gene heterogen ...... immunodeficiency virus type 1.
@en
P2093
J L Albright
M E Quiñones-Mateu
P2860
P304
P577
1998-11-01T00:00:00Z